Controlled Clinical Trials as Topic
"Controlled Clinical Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about clinical trials involving one or more test treatments, at least one control treatment, specified outcome measures for evaluating the studied intervention, and a bias-free method for assigning patients to the test treatment. The treatment may be drugs, devices, or procedures studied for diagnostic, therapeutic, or prophylactic effectiveness. Control measures include placebos, active medicines, no-treatment, dosage forms and regimens, historical comparisons, etc. When randomization using mathematical techniques, such as the use of a random numbers table, is employed to assign patients to test or control treatments, the trials are characterized as RANDOMIZED CONTROLLED TRIALS AS TOPIC.
Descriptor ID |
D018849
|
MeSH Number(s) |
E05.318.760.250.500.365 N05.715.360.775.088.500.387 N06.850.520.450.250.250.365
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Controlled Clinical Trials as Topic".
Below are MeSH descriptors whose meaning is more specific than "Controlled Clinical Trials as Topic".
This graph shows the total number of publications written about "Controlled Clinical Trials as Topic" by people in this website by year, and whether "Controlled Clinical Trials as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2013 | 1 | 1 | 2 |
2017 | 1 | 4 | 5 |
2018 | 4 | 2 | 6 |
2019 | 0 | 1 | 1 |
2020 | 4 | 1 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Controlled Clinical Trials as Topic" by people in Profiles.
-
Plasma convalescent decrease mortality in COVID-19 patients: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2021 Jul; 25(14):4841-4853.
-
Personal protective equipment for reducing the risk of COVID-19 infection among healthcare workers involved in emergency trauma surgery during the pandemic: an umbrella review protocol. BMJ Open. 2021 03 02; 11(3):e045598.
-
Hydroxychloroquine (HCQ): real treatment or false hope? Int J Antimicrob Agents. 2021 Jan; 57(1):106170.
-
COVID-19 vaccine trial ethics once we have efficacious vaccines. Science. 2020 12 11; 370(6522):1277-1279.
-
Why emergency COVID-vaccine approvals pose a dilemma for scientists. Nature. 2020 12; 588(7836):18-19.
-
Scientists criticize use of unproven COVID drugs in India. Nature. 2020 11; 587(7833):187-188.
-
COVID-19 vaccine trials should seek worthwhile efficacy. Lancet. 2020 09 12; 396(10253):741-743.
-
Can interferons stop COVID-19 before it takes hold? Science. 2020 07 10; 369(6500):125-126.
-
Using Controlled Trials to Resolve Key Unknowns About Policy During the COVID-19 Pandemic. JAMA. 2020 Jun 16; 323(23):2369-2370.
-
[COVID-19 - A RECENT REVIEW]. Harefuah. 2020 Jun; 159(6):394-397.